Dr. Cappelli’s research interest involves collaboration with oncologists to study patients developing rheumatic diseases after being treated for their cancer by a new oncology drug.
Rheumatologic Consequences of Immunotherapy to Treat Malignancies: The Tip of an Iceberg
Dr. Antiochos, an Instructor of Medicine at the Sjögren’s center, not only focuses on patient care, but also makes discoveries in research. One of his main goals is to change the trajectory of the disease by identifying components of the immune system that can be targeted with a drug to improve relief.
Dr. Grader-Beck began his career interested by autoimmune diseases. He values building strong relationships with his patients and helping them through every step of the way. He takes away the “unknown” of the disease by informing patients and giving them great medical care.
